Showing 1 - 10 of 34
A model of patent dispute resolution, which alsoconsiders early stage patent and development investments by both the patentowner and the possible defendant, is presented. The model is comprised of three stages involving an investment firm and aninfringing firm. The three stages of the model are...
Persistent link: https://www.econbiz.de/10014201650
Persistent link: https://www.econbiz.de/10002516520
Persistent link: https://www.econbiz.de/10001938316
Persistent link: https://www.econbiz.de/10003932264
Persistent link: https://www.econbiz.de/10003716049
Persistent link: https://www.econbiz.de/10000729854
This paper estimates the total cost of patent litigation to alleged infringers. We use a large sample of stock market event studies around the date of lawsuit filings for US public firms from 1984-99. We find that the total costs of litigation are much greater than legal fees and costs are large...
Persistent link: https://www.econbiz.de/10014050928
Do patents provide critical incentives to encourage investment in innovation? Or, instead, do patents impose legal risks and burdens on innovators that discourage innovation, as some critics now claim? This paper reviews empirical economic evidence on how well patents perform as a property system
Persistent link: https://www.econbiz.de/10014219725
Technological breakthroughs occasionally set off floods of inventions and associated patents. The decline of the business method exception to patentability is likely to increase the frequency of patent floods. Future technological breakthroughs might now cause two different patent floods: a...
Persistent link: https://www.econbiz.de/10014116821
Pharmacogenomics promises to revolutionize medicine by using genetic information to guide drug therapy. Genetic tests will help doctors improve drug safety and efficacy by better matching patients and drugs. This Article evaluates the effectiveness of patent-based incentives to create genetic...
Persistent link: https://www.econbiz.de/10014085303